392 G (Carbidopa and levodopa extended release 25 mg / 100 mg)

Pill imprint 392 G has been identified as Carbidopa and levodopa extended release 25 mg / 100 mg.

Carbidopa/levodopa is used in the treatment of restless legs syndrome; parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 392 G

Carbidopa and levodopa extended release 25 mg / 100 mg 392 G
Carbidopa and levodopa extended release 25 mg / 100 mg 392 G
Carbidopa and levodopa extended release 25 mg / 100 mg 392 G
Carbidopa and levodopa extended release
Imprint:
392
G
Strength:
25 mg / 100 mg
Color:
Purple
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Global Pharmaceuticals
National Drug Code (NDC):
00115-3922
Inactive Ingredients:
hydroxypropyl cellulose
magnesium stearate
FD&C Blue No. 2
FD&C Red No. 40

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)